Picture of Infant Bacterial Therapeutics AB logo

IBT B Infant Bacterial Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product

Dec 12 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST:

SAID ON THURSDAY SECURES PARTNERSHIP WITH BIOCONNECTION FOR PRODUCTION OF DRUG PRODUCT

DRUG PRODUCT PROCESS PERFORMANCE QUALIFICATION PROGRAMME TO BE CONDUCTED AT BIOCONNECTION’S MANUFACTURING FACILITY IN OSS, THE NETHERLANDS

 Source text for Workspace: nMFN45kFLv
 Further company coverage: [IBTb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Infant Bacterial Therapeutics AB

See all news